A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 1,096 shares of VRTX stock, worth $518,188. This represents 0.15% of its overall portfolio holdings.

Number of Shares
1,096
Previous 921 19.0%
Holding current value
$518,188
Previous $431,000 18.1%
% of portfolio
0.15%
Previous 0.15%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

BUY
$460.0 - $505.78 $80,500 - $88,511
175 Added 19.0%
1,096 $509,000
Q2 2024

Jul 05, 2024

BUY
$392.81 - $485.53 $361,778 - $447,173
921 New
921 $431,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $121B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Thurston, Springer, Miller, Herd & Titak, Inc. Portfolio

Follow Thurston, Springer, Miller, Herd & Titak, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thurston, Springer, Miller, Herd & Titak, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thurston, Springer, Miller, Herd & Titak, Inc. with notifications on news.